Dr Berthold Lux > MAIWALD PATENTANWALTS- UND RECHTSANWALTSGESELLSCHAFT MBH > Munich, Germany > Lawyer Profile

MAIWALD PATENTANWALTS- UND RECHTSANWALTSGESELLSCHAFT MBH
MAIWALD PATENTANWALTS- UND RECHTSANWALTSGESELLSCHAFT MBH
ELISENSTRASSE 3, 80335 MÜNCHEN
Germany
Berthold Lux photo

Work Department

Berthold Lux advises and represents clients in the field of chemistry, including polymer and organic chemistry, pharmaceuticals, materials sciences as well as chemical process technology. A large part of his work as a patent attorney involves conducting opposition proceedings on behalf of clients as well as preparing opinions on enforceability, validity and relevance of industrial property rights.

Berthold has been working in the field of intellectual property protection since 1999. After completing his training as a patent attorney, he became co-founder of the patent attorney firm of BLCH, later incorporated into the then Maiwald Patentanwalts GmbH. Berthold Lux has many years of experience is handling opposition proceedings before the EPA, in particular before the Appeal Boards of the EPA.

Position

Partner, German Patent Attorney, European Patent Attorney, European Trademark and Design Attorney

Career

Since 2010

Partner, shareholder and managing director at Maiwald

Since 2007

Patent attorney at Maiwald

2006-2007

Patent attorney and co-founder of an IP law firm

2003-2006

Patent attorney at two different IP law firms

2000-2003

Patent attorney trainee at an IP law firm

1999-2000

Scientific consultant at a New York IP law firm

Languages

German, English

Memberships

VPP

Education

2006

Admitted to practice as European patent attorney

2003

Admitted to practice as German patent attorney

2000-2003

Studied law for patent attorneys at the University of Hagen

1996-1999

Doctoral degree in the field of organic chemistry from the Ludwig Maximilian University of Munich

1990-1996

Studied chemistry and biology at the University of Bayreuth, the University of Vienna and the Ludwig Maximilian University of Munich

Lawyer Rankings

Deutschland > Gewerblicher Rechtsschutz > Patentrecht: Patentanwälte: Anmeldungen und Amtsverfahren

MAIWALD PATENTANWALTS- UND RECHTSANWALTSGESELLSCHAFT MBH wartet mit einer regen Patenterteilungs- und Einspruchsverfahrenspraxis auf und legt einen besonderen Schwerpunkt auf Verfahren vor dem EPA. Von den Büros in München und Düsseldorf aus bietet die Kanzlei zudem Beratung in strategischen Patent- und Portfoliofragen, die Begleitung internationaler Mandate wie beispielsweise die weltweite Koordination von Patenterteilungsverfahren, ein gut aufgestelltes Team für Nichtigkeits- und Verletzungsklagen und Beratung zu ergänzenden Schutzzertifikaten, worauf ein besonderer Fokus liegt. Sektoriell liegt die traditionelle Stärke der Kanzlei im Pharma- und Chemiesektor, man verfügt jedoch auch über tiefgehende Expertise in den Bereichen Biotechnologie, Maschinenbau, Elektrotechnik, computerbezogene Erfindungen und Medizintechnik. Zunehmend sichtbar wird außerdem der Engineering-Flügel. Die Mandantschaft setzt sich aus Start-ups, Mittelständlern und internationalen Großkonzernen zusammen, wobei der Anteil von Mandanten aus den USA und Asien, insbesondere aus China und Japan, stetig wächst. Schlüsselfiguren im Team sind Dirk Bühler (Biotechnologie), Eva Ehlich (Chemie und Pharmazie), Martin Huenges (Biotechnologie und Pharmazie), Derk Vos (Chemie und Pharmazie), Christian Schäflein (Physik), Alexander Ortlieb (Physik, Medizintechnik und Diagnostik, computerimplementierte Erfindungen, Maschinenbau und Telekommunikation), Eva Dörner (Chemie), Angela Zumstein (Pharmazie), Berthold Lux (Chemie), Alexander Schmitz (Elektrotechnik) und Sophie Ertl (Maschinenbau). Der als Patent- und Rechtsanwalt doppelt qualifizierte Stefan Bianchin stieß im Februar 2019 von Mitscherlich & Partner zur Kanzlei und wurde im August 2019 zum Partner ernannt. Naho Fujimoto (Chemie), Ian Weaver (Optoelektronik und optische Informationsverarbeitung) und Christian Pioch (unter anderem Software, Datenverarbeitung und Halbleitertechnik) wurden Ende 2019 beziehungsweise Anfang 2020 in die Partnerschaft aufgenommen.

Germany > Intellectual property > Patent prosecution

MAIWALD PATENTANWALTS- UND RECHTSANWALTSGESELLSCHAFT MBH fields an active patent granting and opposition procedures practice and has a particular focus on proceedings before the EPO. From its Munich and Düsseldorf offices, the firm also offers advice on strategic patent and portfolio issues, assistance with international instructions such as the global coordination of patent granting procedures, a seasoned team for nullity and infringement claims and advice on complementary protection certificates, which represents a particular focus. Sectorally, the firm’s traditional strength lies in the pharmaceuticals and chemicals industries, although the team also possesses deep expertise in the biotechnology, mechanical engineering, electrotechnology, computer-related inventions and medical engineering fields. The engineering practice is also increasingly gaining visibility. The client base is comprised of startups, medium-sized companies and large international corporations, while the share of clients from the US and Asia, particularly China and Japan, is increasingly growing. The team’s key contacts are Dirk Bühler (biotechnology), Eva Ehlich (chemicals and pharmaceuticals), Martin Huenges (biotechnology and pharmaceuticals), Derk Vos (chemicals and pharmaceuticals), Christian Schäflein (physics), Alexander Ortlieb (physics, medical engineering and diagnostics, computer-implemented inventions, mechanical engineering and telecommunications), Eva Dörner (chemicals), Angela Zumstein (pharmaceuticals), Berthold Lux (chemicals), Alexander Schmitz (electrotechnology) and Sophie Ertl (mechanical engineering). Dually qualified patent lawyer and attorney-at-law Stefan Bianchin joined the firm in February 2019 from Mitscherlich & Partner and made partner in August 2019. Naho Fujimoto (chemicals), Ian Weaver (optoelectronics and optical information processing) and Christian Pioch (software, data processing and semiconductor technology among others) made partner at the end of 2019 and the beginning of 2020 respectively.